Other Event

Other Event

Other Adverse Events are non-serious adverse events that exceed a specific frequency threshold (typically 5% within any study arm). These events are reported to provide comprehensive safety information about all noteworthy adverse occurrences during clinical trials. Each other event is categorized by term, organ system, assessment type, and source vocabulary for standardized reporting.

Other Event path is as follows:

Study -> Results Section -> Adverse Events Module -> Other Event

Study -> Results Section -> Adverse Events Module -> Other Event -> Other Event Stats

Other Event


Ignite Creation Date: 2025-12-24 @ 10:17 PM
Ignite Modification Date: 2025-12-25 @ 7:51 PM
NCT ID: NCT00913835
Term: Dry skin
Organ System: Skin and subcutaneous tissue disorders
Assessment Type: SYSTEMATIC_ASSESSMENT
Source Vocabulary: MedDRA 14.1
Notes: None
Study: NCT00913835
Study Brief: A Study of Liposomal Doxorubicin With or Without Olaratumab (IMC-3G3) in Platinum-Refractory or Resistant Advanced Ovarian Cancer
Other Event Stats (If Any):

Other Event Stats

Group ID # Events # Affected # At Risk View
EG000 11 8 62 View
EG001 11 10 61 View
EG002 0 0 28 View